Company Information - EXEL Industries is a French Société Anonyme with a share capital of €16,969,750 [1] - The registered office is located at 54, rue Marcel Paul, 51206 Epernay Cedex, France [1] - The company is registered under the Reims Companies Register (RCS) with the number 095 550 356 [1] Share and Voting Rights - As of May 31, 2025, the total number of shares is 6,787,900 [2] - The theoretical voting rights amount to 9,891,627 [2] - The exercisable voting rights, after deduction of shares without voting rights, are 9,886,797 [2]

Company Overview - Expand Energy Corporation is a leading U.S.-based natural gas producer formed through the merger of Chesapeake Energy Corporation and Southwestern Energy Company, completed on October 1, 2024 [11] - The merger positioned Expand Energy as the largest natural gas producer in the country, leveraging a vast asset base across the Haynesville and Appalachian shale plays [11] - The combined entity has more than 5,000 gross drilling locations and an extensive inventory expected to sustain development for over 15 years [11] Operational Efficiency - The merger enhanced operational scale and efficiency, unlocking cost synergies and providing a strong platform to capitalize on growing natural gas demand, particularly from the liquefied natural gas (LNG) sector [11] Stock Performance - Expand Energy is currently rated 3 (Hold) on the Zacks Rank, with a VGM Score of A [12] - The stock has a Momentum Style Score of B, with shares up 9% over the past four weeks [12] - Four analysts revised their earnings estimate higher in the last 60 days for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.09 to $7.68 per share [12] - The company boasts an average earnings surprise of 72.9% [12] Investment Potential - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, Expand Energy should be on investors' short list [13]

Core Points - Extendicare Inc. has completed the acquisition of nine "Class C" long-term care homes and a parcel of vacant land from Revera Inc. effective June 1, 2025 [1] - The total consideration for the transaction was approximately $60.3 million, consisting of $40.2 million in cash and the assumption of $20.1 million in liabilities [2] - The acquired homes include a total of 822 long-term care beds and 574 retirement beds across various locations in Ontario and Manitoba [3] Financial Details - The purchase price was funded from cash on hand, excluding transaction costs [2] - The liabilities assumed include government funding reimbursement obligations and committed capital maintenance project obligations [2] Operational Insights - Carlingview Manor is undergoing redevelopment into a new 320-bed long-term care home, owned by a joint venture between Extendicare and Axium [4] - Extendicare operates a network of 99 long-term care homes, providing approximately 11.2 million hours of home health care services annually [5] - The company employs around 26,500 qualified team members dedicated to delivering high-quality care [5]

Core Viewpoint - Expand Energy (EXE) shares have increased by approximately 11.1% since the last earnings report, outperforming the S&P 500, but recent estimates have trended downward, indicating potential challenges ahead [1][2]. Group 1: Earnings Performance - The last earnings report for Expand Energy was about a month ago, and the stock has shown positive performance since then [1]. - The consensus estimate for the company has decreased by 9.3% over the past month, reflecting a negative shift in expectations [2]. Group 2: VGM Scores - Expand Energy currently holds a strong Growth Score of A, but has a lower Momentum Score of D, indicating mixed performance across different investment strategies [3]. - The stock has a value grade of C, placing it in the middle 20% for this investment strategy, leading to an overall aggregate VGM Score of B [3]. Group 3: Outlook - The overall trend for estimates has been downward, suggesting a potential decline in performance expectations for Expand Energy [4]. - The company holds a Zacks Rank of 3 (Hold), indicating an expectation of an in-line return in the coming months [4].

Core Points - Extendicare Inc. held its annual and special meeting of shareholders on May 27, 2025, where various matters were voted on [1] - A total of 47,282,730 common shares were represented at the meeting, accounting for 56.41% of the outstanding shares [2] Group 1: Election of Directors - Nine nominees were elected as directors to serve until the next annual meeting [3] - The voting results showed high approval rates for the nominees, with votes for ranging from 94.08% to 99.74% [4] Group 2: Appointment of Auditors - KPMG LLP was appointed as the auditors of the Company until the next annual meeting, with 87.18% of votes in favor [5][6] Group 3: Long Term Incentive Plan - The resolution to approve unallocated entitlements under Extendicare's Long Term Incentive Plan was passed with 97.04% approval [7][8] Group 4: Executive Compensation - A non-binding advisory resolution regarding the Company's approach to executive compensation was approved, receiving 94.48% of votes in favor [9][10][11] Company Overview - Extendicare is a leading provider of care and services for seniors in Canada, operating 122 long-term care homes and delivering approximately 11.2 million hours of home health care services annually [12]

Core Viewpoint - EXEL Industries reported a decline in revenue and recurring EBITDA for the first half of 2024-2025, primarily due to lower volumes in Agricultural Spraying, while maintaining a focus on debt reduction and cash flow optimization [5][13]. Financial Performance - Revenue for the first half of 2024-2025 was €443.4 million, down 10.0% from €492.7 million in the same period of 2023-2024 [5][6]. - Recurring EBITDA decreased to €20.3 million, representing 4.6% of revenue, compared to 6.2% in the previous year [7][5]. - Net income was €1.5 million, a decline from €4.7 million in the first half of 2023-2024 [7][5]. Debt and Cash Flow Management - The Group's net financial debt improved by €38 million, standing at €174.5 million compared to €212.7 million in the previous year, due to efforts in reducing working capital requirements (WCR) and inventory levels [9][5]. - Despite a negative change in WCR of €30 million, the Group's focus on cash flow generation and debt reduction remains a priority [9][13]. Segment Performance - Agricultural Spraying revenue fell by €53.4 million, or 21.5%, reflecting a significant decline in volumes [4][6]. - Other segments, such as Sugar Beet and Industrial Spraying, showed stable or slight growth, with Sugar Beet revenue remaining relatively unchanged [4][6]. Future Outlook - Order intake in Agricultural Spraying is showing limited visibility but signs of recovery in Europe, while market conditions for Sugar Beet Harvesting remain uncertain [12][15]. - The Group plans to continue aligning production capacities and cost structures with business levels in response to lower volumes [15][12]. Investment and Capex - Capital expenditures (Capex) amounted to €15.6 million, including ongoing construction of a new plant in Stains, France [10].

Group 1 - EXEL Industries is a French Société Anonyme with a share capital of €16,969,750 [1] - The registered office is located at 54, rue Marcel Paul, 51206 Epernay Cedex, France [1] - The company is registered under the Reims Companies Register (RCS) with the number 095 550 356 [1] Group 2 - As of April 30, 2025, the total number of shares is 6,787,900 [2] - The theoretical voting rights amount to 9,891,627 [2] - The exercisable voting rights, after deduction of shares without voting rights, are 9,885,698 [2]

Core Insights - Extendicare Inc. reported strong results for Q1 2025, driven by growth across all business segments and positive operating performance [4][9] - The company is actively pursuing growth initiatives, including the acquisition of Closing the Gap and the purchase of nine LTC homes from Revera [4][7] Financial Performance - Adjusted EBITDA increased by $8.7 million or 42.7% to $29.0 million, reflecting improvements across all business segments [9] - Revenue for Q1 2025 was $374.7 million, an increase of $7.6 million compared to Q1 2024, with a 5.8% increase when excluding out-of-period funding [16] - Net earnings rose by $1.9 million to $15.0 million, largely due to the increase in Adjusted EBITDA [16] Business Segment Performance - Long-term care revenue decreased by $8.7 million to $197.8 million, but improved when excluding out-of-period funding [14] - Home health care revenue increased by $14.7 million to $158.3 million, driven by an 8.9% increase in average daily volume [19][17] - Managed services revenue rose by $1.6 million or 9.2% to $18.6 million, attributed to growth in SGP clients [22] Strategic Developments - The company completed the sale of three LTC homes under construction for net cash proceeds of $56.3 million, resulting in an estimated gain of $11.1 million [6] - Extendicare is on track to finalize the acquisition of nine LTC homes from Revera, expected to close in Q2 2025 [7] Operational Metrics - LTC average occupancy remained stable at 97.5% [13] - Home health care average daily volume reached 31,603, an increase of 8.9% from Q1 2024 [17] Financial Position - As of March 31, 2025, Extendicare had cash and cash equivalents of $109.5 million, with access to an additional $108.5 million under its credit facility [23] - AFFO increased to $19.8 million ($0.235 per basic share) from $17.6 million ($0.210 per basic share) [16]

Group 1 - Expand Energy (EXE) is a member of the Oils-Energy group, which consists of 246 companies and is currently ranked 15 in the Zacks Sector Rank [2] - The Zacks Rank system emphasizes earnings estimates and revisions, with Expand Energy holding a Zacks Rank of 1 (Strong Buy) [3] - Over the past 90 days, the Zacks Consensus Estimate for EXE's full-year earnings has increased by 62.9%, indicating improved analyst sentiment [3] Group 2 - Year-to-date, Expand Energy has returned approximately 4.4%, while the Oils-Energy group has seen an average loss of about 8% [4] - Golar LNG (GLNG) is another stock in the Oils-Energy sector that has outperformed, with a return of 0.4% since the beginning of the year [4] - Expand Energy belongs to the Alternative Energy - Other industry, which includes 44 stocks and is currently ranked 182 in the Zacks Industry Rank, with an average loss of 0.4% this year [5] Group 3 - Golar LNG is part of the Oil and Gas - Integrated - International industry, which consists of 17 stocks and is currently ranked 183, with a year-to-date decline of 5.7% [6] - Investors interested in Oils-Energy stocks should monitor both Expand Energy and Golar LNG for their continued strong performance [6]

Core Viewpoint - Extendicare Inc. announced the acquisition of Closing the Gap Healthcare Group Inc. by its subsidiary ParaMed Inc. for approximately $75.5 million, enhancing its home health care services in Ontario and Nova Scotia [1][3][4]. Transaction Details - The acquisition is structured on a debt-free, cash-free basis, with an earnout tied to new business revenue generation expected in the first year post-closing [3][8]. - The transaction is subject to customary closing conditions and is anticipated to close in the third quarter of 2025 [2]. Company Background - Closing the Gap has been a leader in home and community healthcare for 35 years, providing a range of services including personal support, nursing, physiotherapy, and social work [5][4]. - In 2024, Closing the Gap delivered over 1.1 million service hours through approximately 1,200 caregivers [5]. Financial Impact - The acquisition is projected to add approximately $84.2 million in revenue to Extendicare's home health care segment for 2024, with similar margins to ParaMed [6]. - The combined service volumes for the home health care segment would reach approximately 12.1 million hours with an average daily volume of 33,164 [7]. - The earnout from the transaction is estimated to be between $3.5 million and $5.5 million, contributing an additional $7.0 to $11.0 million in revenue [8]. Synergies and Growth Potential - The integration of back-office functions is expected to generate approximately $1.1 million in annualized cost synergies in the first year following the closing [8]. - The acquisition is seen as a strategic move to enhance Extendicare's capabilities and market presence in the home health care sector [4].